NasdaqGM - Delayed Quote USD

Aspire Biopharma Holdings, Inc. (ASBP)

Compare
1.0100
-0.4900
(-32.67%)
At close: March 3 at 4:00:03 PM EST
1.0201
+0.01
+(1.00%)
After hours: 7:58:56 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
646.6630
358.5900
596.4910
Operating Income
-646.6630
-358.5900
-596.4910
Pretax Income
-646.6630
-358.5900
-596.4910
Tax Provision
1.4940
0.4810
0.6260
Net Income Common Stockholders
-648.1570
-359.0710
-597.1170
Diluted NI Available to Com Stockholders
-648.1570
-359.0710
-597.1170
Basic EPS
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
Basic Average Shares
45,937.5000
45,937.5000
45,937.5000
Diluted Average Shares
45,937.5000
45,937.5000
45,937.5000
Total Expenses
646.6630
358.5900
596.4910
Net Income from Continuing & Discontinued Operation
-648.1570
-359.0710
-597.1170
Normalized Income
-648.1570
-359.0710
-597.1170
EBIT
-646.6630
-358.5900
-596.4910
EBITDA
-646.6630
-358.5900
-596.4910
Net Income from Continuing Operation Net Minority Interest
-648.1570
-359.0710
-597.1170
Normalized EBITDA
-646.6630
-358.5900
-596.4910
Tax Rate for Calcs
0.0002
0.0002
0.0002
12/31/2022 - 4/11/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers